Economic Overview
Global Economy1
The global economy demonstrated resilience in CY 2024, navigating a challenging landscape marked by geopolitical tensions, trade uncertainties, and effects of prolonged monetary tightening. Despite these headwinds, global GDP growth held steady at 3.3%, supported by easing inflationary pressures across key economies.
Emerging Markets and Developing Economies (EMDEs) remained the primary engines of global expansion, growing at a robust pace of 4.3%. Strong domestic demand and sustained foreign investment underpinned this performance. In contrast, advanced economies recorded modest growth of around 1.8%, constrained by subdued industrial activity and tighter fiscal conditions.
Inflationary trends showed significant improvement, with global inflation easing to 5.7% in CY 2024, down from 6.7% in the previous year. This was largely driven by stabilising energy and food prices, improved supply chain conditions, and easing labour market constraints. In response, several central banks, including the U.S. Federal Reserve, began shifting from a stance of monetary tightening to more expansionary policies, aimed at stimulating growth and enhancing credit availability. Global trade also showed signs of recovery, with trade volumes increasing by an estimated 3.4%, driven by robust export performance in the U.S., China, and East Asia.
: Outlook
The global economic outlook for CY 2025 and beyond remains moderately positive, underpinned by easing inflationary pressures, improved macroeconomic stability, and a gradual recovery in investment activity. Global GDP growth is projected at 2.8% in CY 2025 and 3.0% in CY 2026. Advanced economies are expected to experience modest growth, supported by accommodative monetary policies and a gradual improvement in consumer and business confidence. Meanwhile, Emerging Markets and Developing Economies are projected to maintain their growth momentum with 3.7%%, benefitting from demographic dividends, infrastructure expansion, and accelerating digital transformation.
Inflation is anticipated to continue on a downward trajectory. Global inflation is expected to decline to approximately 4.3% in CY 2025 and further to 3.6% in CY 2026. However, challenges persist. Global trade growth is projected to remain subdued, with estimates suggesting a slowdown to 1.7% in 2025. This is largely attributed to rising tariff barriers, geopolitical tensions, and the waning impact of recent cyclical trade drivers. Despite these risks, the global economy is expected to remain on a stable path, supported by structural reforms, steady domestic demand in key markets, and the continued shift towards more supportive economic policies.
Indian Economy
India showed steady growth in FY 2024-25 with a growth rate of 6.5%2, propelled by strong domestic demand and the steady rise of urban middle class. Inflationary pressures have notably eased during the year, with consumer price inflation reaching as low as 3.34% during the year. This reduction in inflation enabled the Reserve Bank of India to adopt a more accommodative monetary policy stance, which in turn improved liquidity conditions and supported both consumption and investment activities across the economy.
The Governments firm focus on infrastructure led growth was underscored by a significant capital expenditure allocation of B11.11 lakh crore in the Union Budget. Within this broader economic framework, the healthcare sector has emerged as a key driver, benefiting from increased public and private sector investments. With government initiatives aimed at strengthening healthcare infrastructure, alongside private sector efforts in medical innovation and accessibility, the healthcare industry is playing an increasingly critical role in fostering economic resilience and promoting inclusive development.
: Outlook
Indias economic prospects for the coming year remain strong, underpinned by solid macroeconomic fundamentals and consistent policy direction. GDP growth is expected to hold steady at around 6.5%3, reflecting the economys resilience and broad based momentum. Inflation is forecasted to stay within a manageable range, hovering near 4.0%. This sustained moderation in price levels opens the door for potential monetary easing, which could further enhance credit availability and stimulate consumer demand across key sectors.
A major pillar of the countrys growth outlook continues to be the Governments emphasis on infrastructure led development. Strategic investments in physical and digital infrastructure are set to fuel job creation, attract private investment, and reinforce long term economic expansion. Together, these factors position India for continued growth and stability in the medium term.
Industry Overview
Global Healthcare Industry4
The global healthcare industry stands as one of the most vital and rapidly expanding sectors worldwide. Driven by key factors such as population growth, aging demographics, rising income levels and ongoing medical advancements, the industry continues to experience robust expansion. Increased access to healthcare products and services, coupled with a growing need for new and more effective therapies, further underscores the sectors long-term importance.
Innovation remains central to this growth. Breakthroughs in medical treatments, healthcare delivery models, and digital technologies are fundamentally reshaping how care is provided. Digitisation is enhancing the patient experience, enabling
healthcare systems to become more personalised, predictive, and preventative. However, the global healthcare landscape is not without its challenges. Workforce shortages, rising care costs, and persistent disparities in health equity are creating new priorities for governments, providers, and industry stakeholders. These pressures are prompting systemic shifts across policy, investment, and service models.
The sector is broadly segmented into pharmaceuticals, healthcare services, medical devices, and other related fields. With ongoing demand across these segments, the global healthcare market is projected to reach USD 665.37 billion by 2028.
Indian Healthcare Industry
Indias healthcare sector has evolved into one of the countrys most dynamic and rapidly growing industries, playing a crucial role in shaping a healthier and more inclusive future. With a strong foundation in innovation, the industry has led the way in developing cost-effective medical products and services that serve both domestic and global markets.5
Over the past few decades, the sector has undergone transformative changes, marked by significant improvements in infrastructure, technology integration, and accessibility. Public health initiatives have successfully contributed to higher life expectancy, lower fertility rates, and reduced maternal and child mortality. These achievements reflect steady advancements in healthcare delivery systems, driven by both targeted government reforms and strategic investments in medical infrastructure. Spanning a wide range of services, including hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment, the Indian healthcare sector has emerged as one of the largest contributors to national revenue and employment.
Looking ahead, the industry is poised for substantial expansion, with its market size projected to reach USD 638 billion by the end of 20256. This growth is being propelled by increased public and private investments, rising health awareness, and improved access to medical services across both urban and rural areas. The surge in healthcare infrastructure development, particularly in Tier 2 to Tier 6 cities, further underscores this momentum. With average household incomes on the rise and increased spending from both government and private sectors, Indias healthcare expenditure is expected to grow significantly, offering immense potential for continued sectoral growth when compared to other major economies.
Healthcare Sector Growth Trend (US$ billion)
in favour of the consumer. Recent interventions are focused on simplifying policyholder experiences and fostering digital innovation. At the same time, the emergence of private players has significantly improved operational efficiency, technological adoption, and service delivery standards across the industry.
The health insurance segment, valued at approximately USD 15.99 billion in 2024, is projected to reach USD 38.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.5%. This trajectory reflects growing consumer awareness, rising medical expenses, and an expanding array of tailored insurance products.
Healthcare Sector Growth Trend (US$ billion)
Health Insurance Industry7
Indias health insurance sector presents both considerable challenges and vast opportunities. A significant portion of the population and assets remain uninsured, underscoring the urgent need for deeper market penetration and broader financial protection. Driven by a combination of rising healthcare costs, an expanding middle class, increased post-pandemic awareness of health risks, and supportive regulatory policies, the sector is poised to enter a steep growth phase8. These factors are strong prospects for Indias insurance industrys rapid expansion and sustained profitability. India has already outpaced several Asian peers in premium growth and has garnered impressive market valuations. Indian life insurers, have achieved valuation multiples of seven to ten times price-to-book, reflecting robust investor confidence and consistent performance.
The regulatory environment, led by the Insurance Regulatory and Development Authority of India (IRDAI), continues to evolve
Opportunities9
Medical Devices and Diagnostics
India ranks among the top 20 global markets for medical devices, driven by growing demand for imaging equipment, diagnostic kits, and minimally invasive technologies. Tier-2 and tier-3 cities, in particular, present significant growth potential due to expanding healthcare access and rising awareness of early disease detection.
Biopharmaceuticals and Generics
Indias established strength in generic drug manufacturing and its rapidly advancing biopharmaceutical industry create opportunities for strategic collaborations. The country is well- positioned to support global clinical trials and cost effective drug production, making it an attractive destination for innovation, outsourcing, and partnership in life sciences.
6
https://www.bajajamc.com/sites/default/files/amcfiles/Press%20report_Indian_Healthcare_Market_projected_to_reach_%24638_billion_by_2025.pdf7
https://www.insurancebusinessmag.com/asia/news/life-insurance/indias-health-insurance-boom-set-to-triple-by-2032-536660.aspx8
https://www.mckinsey.com/in/our-insights/steering-indian-insurance-from-growth-to-value-in-the-upcoming-techade9
https://www.openpr.com/news/4032556/strategic-market-entry-into-india-s-healthcare-sectorWith increasing smartphone usage and internet penetration, India offers immense potential for digital health innovation. Technologies like telemedicine, AI powered diagnostics, and remote patient monitoring are transforming healthcare delivery, particularly in underserved regions by enhancing accessibility, reducing costs, and enabling timely, patient-centric care across the country.
EplS Healthcare Infrastructure and Hospital Chains
India is witnessing rapid growth in hospital infrastructure through public-private partnerships and private investments. This expansion creates opportunities for integrating advanced medical technologies and healthcare IT systems, driving improved patient outcomes, operational efficiency, and greater access to high quality healthcare services across both urban and rural areas.
Rising Population and an Ageing Demographic
Indias growing and ageing population is significantly increasing demand for quality healthcare. Improved life expectancy is prompting a surge in need for geriatric care, chronic disease management, and specialised services. As a result, providers are expanding capacity and tailoring infrastructure to address this demographic shift, opening sustained growth avenues.
Threats
Regulatory Compliance
Navigating Indias complex and evolving regulatory environment remains a significant challenge for healthcare providers. Frequent policy changes, multi-tiered governance, and fragmented oversight across states can delay approvals, increase operational costs, and hinder innovation.
Variations in Healthcare Access Across Regions
India faces stark disparities in healthcare access between urban and rural areas. While metropolitan regions often benefit from advanced medical facilities, large parts of the population in remote and underserved regions still lack basic healthcare services. This uneven distribution undermines national health outcomes and equitable care delivery.
India continues to experience a critical shortage of trained healthcare professionals, including doctors, nurses, and technicians. The shortage is particularly acute in rural areas, affecting patient care quality and increasing the burden on existing staff. This gap limits the systems ability to scale and respond to rising demand.
Low Insurance Penetration
Despite policy reforms, health insurance penetration in India remains low. A significant portion of the population remains uninsured or underinsured, leading to high spending. This financial vulnerability not only discourages preventive care but also limits the healthcare systems ability to deliver consistent, affordable services at scale.
Government Initiatives
Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM)
PM-ABHIM strengthens Indias healthcare infrastructure across all levels by investing in public health labs, emergency response systems, and digital health technologies. It is Indias largest public health infrastructure initiative since 2005, aiming to enhance healthcare accessibility and resilience through technology driven reforms.
National Health Mission (NHM)
The NHM supports the enhancement of healthcare infrastructure and human resources in rural and underserved regions. It provides technical and financial assistance to states and UTs, ensuring improved access to quality health services in line with the National Health Policys broader goals.
Health Data Management Policy
Aligned with the National Digital Health Blueprint and NHP 2017, this policy supports creation of a digital infrastructure to deliver universal health coverage. It promotes Atma Nirbhar Bharat by enabling secure, standardized health data systems for nationwide integration of healthcare services.
Ayushman Bharat Digital Mission (ABDM)
ABDM aims to establish a unified digital health ecosystem by integrating healthcare providers and patients using unique health IDs. It bridges gaps in infrastructure and public health management across urban and rural areas, empowering communities to manage health crises independently and effectively.
The e-Sanjeevani platform provides remote healthcare consultations, reducing the need for physical visits and ensuring continuity of care. It has been pivotal during the pandemic, enabling doctor consultations from home and expanding access to medical advice, particularly in underserved and rural areas.
Aarogya Setu App
The Aarogya Setu App has evolved into a comprehensive National Health App under ABDM. It enables users to create health IDs, access digital lab reports and prescriptions, schedule teleconsultations via e-Sanjeevani, and manage COVID-19 vaccination certificates, all through a single, integrated digital platform.
U-WIN Portal
Launched in October 2024, the U-WIN Portal digitizes vaccination services for pregnant women and children. It offers anytime-anywhere vaccination access, self-registration, SMS alerts, digital certificates, and supports creation of Ayushman Bharat Health Accounts for individuals and children, enhancing transparency and accessibility in immunization efforts.
Company Overview
Krishna Institute of Medical Sciences Limited (KIMS) is one of Indias largest corporate healthcare groups, with a robust footprint across Telangana, Andhra Pradesh, Maharashtra, Kerala, and Karnataka. Operating under the trusted KIMS Hospitals brand, the Company delivers integrated, multidisciplinary healthcare services with a focus on tertiary and quaternary care, underscoring its commitment to clinical excellence at an affordable cost.
KIMS manages a network of advanced multi-specialty hospitals, comprising a combined capacity of over 5,000 beds. Its comprehensive service offering spans more than 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics, organ transplantation, renal sciences, and mother and child care.
The Companys growth and reputation are rooted in its unwavering commitment to delivering accessible, high- quality healthcare and its strong relationships with skilled medical professionals. These pillars have been instrumental in strengthening the KIMS Hospitals brand and enhancing its role as a trusted healthcare provider in the regions it serves.
KIMS Foundation and Research Centre (KFRC)
Established in 2010 by Dr. Bhaskar Rao Bollineni, Chairman & Managing Director of KIMS Hospitals, the KIMS Foundation and Research Centre (KFRC) is at the forefront of diverse and innovative scientific research in healthcare. As the research arm of KIMS Hospitals, KFRC is committed to advancing clinical knowledge, improving patient outcomes, and contributing to the broader field of medical science. KFRC engages in multidisciplinary research activities spanning biotechnology, genomics, pharmacology, medical engineering,
and translational medicine. Its work is underpinned by a strong foundation of academic rigor and a clear focus on real-world healthcare applications.
The Centre has forged strategic collaborations with several premier institutions including the Defence Institute of Advanced Technology (DIAT), Indian Institute of Chemical Technology (IICT), University of Hyderabad, and the Genome Foundation. These partnerships have enriched KFRCs intellectual ecosystem by providing access to cutting-edge expertise and fostering a culture of innovation. Notably, these alliances have enabled the development of collaborative PhD programs and joint supervision of research scholars, further strengthening KFRCs academic infrastructure. Through such initiatives, KFRC continues to attract high calibre talent and solidify its position as a hub for pioneering research and scientific advancement in the healthcare sector.
Medical education programmes
KIMS Hospitals remains deeply committed to nurturing the next generation of healthcare professionals through robust medical education programmes. In affiliation with state medical boards and universities, the hospitals offer a comprehensive range of broad and super specialty training, including Diplomate of National Board (DNB) courses and post-doctoral fellowships across various disciplines. These programmes are designed to impart advanced clinical knowledge and hands-on experience, fostering a culture of academic excellence and ethical medical practice. The educational initiatives are further enriched by the work of KIMS Foundation and Research Centre (KFRC), which plays a pivotal role in bridging medical education with scientific research and innovation.
KFRC has entered into strategic collaborations with premier institutions such as the Defence Institute of Advanced Technology (DIAT), Indian Institute of Chemical Technology (IICT), and the University of Hyderabad. These partnerships facilitate joint academic programs, research projects, and PhD level training in cutting edge areas like cancer drug delivery systems, blood embolic agents, biotechnology, and medical engineering. In addition to institutional collaborations, KFRC promotes inclusive and community oriented education through associations with organizations such as the Public Health Foundation of India (PHFI), Tech Mahindra Foundation, and Deaf Enabled Foundation (DEF). Initiatives include mobile cancer screening units, youth skill development, and the establishment of SIGNCARE, a Telemedicine Centre catering to the hearing impaired. Collaboration with the Genome Foundation has further strengthened academic infrastructure by offering access to advanced laboratory facilities and training in molecular genetics and cytogenetics. These efforts have expanded opportunities for DNB and PhD students to undertake high- impact research projects.
Together, KIMS Hospitals and KFRC are shaping a dynamic academic ecosystem that integrates medical education, translational research, and social responsibility, empowering students and healthcare professionals to meet the evolving challenges of modern medicine.
Operational Performance
Particulars |
Telangana | Andhra Pradesh | ||||||||
FY24 | FY25 | Q4 FY24 | Q3 FY25 | Q4 FY25 | FY24 | FY25 | Q4 FY24 | Q3 FY25 | ||
Q4 FY25 |
||||||||||
Bed Capacity | 1727 | 1797 | 1727 | 1797 | 1797 | 1914 | 2214 | 1914 | 2214 | 2214 |
Operational Beds | 1612 | 1682 | 1612 | 1682 | 1682 | 1641 | 1806 | 1641 | 1841 | 1806 |
Census Beds | 1324 | 1394 | 1324 | 1394 | 1394 | 1470 | 1641 | 1470 | 1670 | 1641 |
Non Census Beds | 288 | 288 | 288 | 288 | 288 | 171 | 200 | 171 | 171 | 200 |
Occupied Beds | 849 | 854 | 820 | 845 | 851 | 1154 | 1092 | 1077 | 1062 | 985 |
Occupancy % | 52.6% | 50.8% | 50.9% | 50.2% | 50.6% | 70.3% | 60.5% | 65.6% | 57.7% | 54.6% |
IP Volume | 82,831 | 91,159 | 20,142 | 22,267 | 22,322 | 93,572 | 99,266 | 22,505 | 25,036 | 23,929 |
OP Volume | 8,05,920 | 9,01,117 | 2,10,521 | 2,23,253 | 2,21,049 | 6,70,011 | 7,22,487 | 1,67,104 | 1,81,766 | 1,74,765 |
ARPOB (Rs.) | 53,246 | 63,650 | 56,165 | 63,363 | 65,375 | 15,996 | 21,130 | 17,416 | 21,275 | 23,668 |
ARPP (Rs.) | 1,99,652 | 2,15,676 | 2,08,128 | 2,21,250 | 2,24,316 | 72,198 | 81,416 | 75,809 | 83,061 | 87,721 |
ALOS | 4 | 3 | 4 | 3 | 3 | 4 | 4 | 4 | 4 | 4 |
Total Revenue (Rs. Mn) |
16,572.0 | 19,710.8 | 4,183.5 | 5,027.4 | 4,964.2 | 6,774.5 | 8,108.2 | 1,714.1 | 2,087.9 | 2,108.9 |
EBITDA (Rs. Mn) | 4,777.5 | 6,062.4 | 1,170.2 | 1,547.5 | 1,605.5 | 1,505.7 | 1,962.0 | 370.6 | 494.1 | 495.6 |
EBITDA % to Revenue | 28.8% | 30.8% | 28.0% | 30.8% | 32.3% | 22.2% | 24.2% | 21.6% | 23.7% | 23.5% |
Particulars |
Maharashtra | 1 | Group | ||||||||||
FY24 | FY25 | Q4 FY24 | Q3 FY25 | Q4 FY25 | FY24 | FY25 | Q4 FY24 | Q3 FY25 | |||||
Q4 FY25 |
|||||||||||||
Bed Capacity | 334 | 659 | 334 | 659 | 659 | 509 | 189 | 509 | 3975 | 5179 | 3975 | 4859 | 5179 |
Operational Beds | 250 | 630 | 250 | 630 | 630 | 374 | 189 | 374 | 3503 | 4492 | 3503 | 4342 | 4492 |
Census Beds | 195 | 545 | 195 | 545 | 545 | 344 | 159 | 344 | 2989 | 3924 | 2989 | 3768 | 3924 |
Non Census Beds | 55 | 85 | 55 | 85 | 85 | 30 | 30 | 30 | 514 | 603 | 514 | 574 | 603 |
Occupied Beds | 145 | 208 | 148 | 203 | 230 | 94 | 90 | 90 | 2148 | 2248 | 2044 | 2200 | 2157 |
Occupancy % | 58.0% | 33.0% | 59.1% | 32.2% | 36.6% | 25.2% | 47.4% | 24.0% | 61.3% | 50.1% | 58.4% | 50.7% | 48.0% |
IP Volume | 14,764 | 17,887 | 3,721 | 4,423 | 4,920 | 5,034 | 2,287 | 2,747 | 1,91,167 | 2,13,346 | 46,368 | 54,013 | 53,918 |
OP Volume | 1,12,066 | 1,40,401 | 33,231 | 33,609 | 34,207 | 70,307 | 31,531 | 38,776 | 15,87,997 | 18,34,312 | 4,10,856 | 4,70,159 | 4,68,797 |
ARPOB (Rs.) | 33,782 | 32,052 | 35,520 | 29,836 | 32,591 | 29,885 | 27,191 | 32,727 | 31,916 | 39,158 | 34,270 | 38,472 | 41,469 |
ARPP (Rs.) | 1,21,517 | 1,31,299 | 1,28,301 | 1,26,047 | 1,37,300 | 95,308 | 97,971 | 93,090 | 1,31,232 | 1,43,293 | 1,37,500 | 1,44,181 | 1,49,069 |
ALOS | 3.60 | 4.10 | 3.61 | 4.22 | 4.21 | 3.19 | 3.60 | 2.84 | 4.11 | 3.66 | 4.01 | 3.75 | 3.59 |
Total Revenue |
1,796.5 | 2,365.0 | 478.3 | 561.1 | 680.3 | 486.1 | 225.5 | 260.6 | 25,143.0 | 30,670.0 | 6,376.0 | 7,902.0 | 8,014.0 |
(Rs. Mn) |
|||||||||||||
EBITDA (Rs. Mn) | 249.9 | 220.6 | 87.2 | 7.5 | 21.8 | -97.0 | 0.9 | -97.9 | 6,533 | 8,148.0 | 1,628.0 | 2,050.0 | 2,025.0 |
EBITDA % | 13.9% | 9.3% | 18.2% | 1.3% | 3.2% | -20.0% | 0.4% | -37.6% | 26.0% | 26.6% | 25.5% | 25.9% | 25.3% |
to Total Revenue |
Financial Overview
In FY25, KIMS Hospitals delivered a strong performance, recording a consolidated income of Rs. 3,067 crores at a year-on-year growth of 22%. EBITDA also increased by 24.7% compared to FY24, reflecting the Companys sound operational efficiency and solid financial position.
Particulars |
In Millions FY 2025 | In Millions FY 2024 |
Income |
||
Operating Revenues | 30,351 | 24,982 |
Other Income | 319 | 161 |
Total Income |
30,670 | 25,143 |
Expenses |
||
Purchase of medical drugs | 6,404 | 5,369 |
Changes in inventories of medical drugs | -135 | -65 |
Employee benefits expenses | 4,995 | 4,224 |
Other expenses | 11,258 | 9,082 |
Depreciation and Amortisation expense | 1,772 | 1,465 |
Share of loss from associate, net of tax | - | 3 |
Finance costs | 903 | 470 |
Operating Profit / PBT |
5,473 | 4,595 |
Gain on fair valuation of call option | 108 | |
Operating Profit Margin (%) | 17.80 | 18.30 |
EBITDA |
8,148 | 6,533 |
EBITDA Margin (%) | 26.60 | 26.00 |
Technology and Cybersecurity
The Company has strengthened its cybersecurity framework through real-time monitoring, endpoint protection, and integration of threat intelligence. Key measures include the use of SIEM tools, IDS/IPS systems, and regular third-party vulnerability assessments. Security protocols align with CIS Controls and are supported by regular employee training and incident response drills. With endpoints forming a major part of the digital environment, focused investments have been made in behavioral analytics and threat detection.
Human Resource
KIMS Hospitals recognises that its people are fundamental to delivering high-quality healthcare and sustaining long-term organisational growth. The Company remains committed to effective human resource management as a strategic pillar, ensuring it attracts, retains, and nurtures top-tier talent across all levels of operation. With a dedicated Human Resources department, KIMS Hospitals implements progressive, peoplecentric policies that foster a positive and inclusive work culture. These efforts are aimed at empowering employees, enhancing job satisfaction, and aligning the workforce with the Companys mission of patient-centred care.
As of March 31,2025, KIMS Hospitals, including its subsidiaries, employed over 10,000 individuals. This diverse workforce brings a rich blend of experiences and backgrounds, united by a shared dedication to improving patient health outcomes. The Company
actively fosters diversity and inclusion as a core component of its organisational culture, offering fair and equal opportunities for individuals from all backgrounds to contribute and grow.
Continuous professional development remains a key HR priority. The HR team regularly organises mandatory training sessions and skill enhancement programmes, equipping employees with the tools and knowledge required to adapt and excel in a dynamic healthcare environment. All employees are required to complete a minimum of 40 hours of training annually. Internal and external training programmes are conducted on topics including HR policies, NABH & ISO standards, occupational hazards, POSH, grievance handling, hospital disaster management, privileging processes, IT security, and the use of Adrenalin, LMS and PMS systems. Additionally, external workshops on financial management, clinical governance, womens safety, self-defense, and cybercrime are held periodically. KIMS also prioritises workplace safety through regular mock drills and training sessions on fire safety, radiation safety, incident reporting, and basic life support (BLS).
KIMS takes pride in celebrating its people. Achievements and exceptional contributions by staff are recognised through town hall meetings and award ceremonies. Security personnel and other frontline workers are honoured on national occasions such as Independence Day and Republic Day by senior leadership, including the Managing Director. Through a holistic and inclusive approach to human resources, KIMS Hospitals continues to leverage the collective strength of its people to drive operational excellence and deliver exceptional patient care.
Risk Management
Particular |
Risk |
Mitigation Strategies |
Clinical risk arises from medical errors, misdiagnosis, surgical complications, and procedural mistakes, which can jeopardize patient safety and the quality of care. These risks can adversely affect the Companys reputation and operational integrity. | To minimize clinical risks, KIMS Hospitals implements rigorous safety audits, stringent quality control measures, and continuous training programs for staff. | |
Regulatory Risk |
Regulatory risk refers to the challenges hospitals face in complying with a complex and ever- evolving set of regulations. Non-compliance with these regulations can result in legal penalties, financial losses, and damage to the hospitals reputation. | Compliance with healthcare regulations is ensured through continuous monitoring and updating of practices. |
Financial Risk |
Volatile interest rates, changes in tax laws, and credit risks have the potential to impact the Companys financial stability. These factors can lead to fluctuations in borrowing costs, affect cash flows, and increase the risk of defaults, all of which may negatively influence the Companys profitability and overall financial health. | KIMS Hospitals proactively manages debt, conducts regular risk assessments, and implements strict financial controls to ensure long-term financial stability. |
Operational risk refers to the potential for delays, inefficiencies, or failures in internal processes, systems, or external events that can disrupt hospital operations, ultimately impacting the hospitals ability to deliver timely and quality services to patients. | The Company ensures timely project completion and cost control by implementing efficient project management practices and maintaining operational flexibility. |
Particular |
Risk |
Mitigation Strategies |
Reputational Risk |
Reputational risk refers to the potential damage to a hospitals image or public perception due to negative media coverage, unauthorized statements, or perceived negligence. This can undermine trust, erode patient confidence, and impact business outcomes. | To protect and enhance its reputation, KIMS Hospital prioritizes patient safety while leveraging proactive public relations strategies and maintaining open communication channels. |
Cybersecurity Risk |
Growing reliance on digital systems increases the risk of cyberattacks and data breaches, potentially compromising sensitive information and disrupting operations, which may impact the Companys image and trustworthiness. | The Company maintains strong IT security, supports comprehensive data management, and ensures business continuity through effective disaster recovery protocols. |
Internal Control System and Its Adequacy
The Company adheres to the principles of fair representation and full disclosure in all its dealings and communications. Its annual report, results, presentations, and other forms of corporate and financial communications are designed to provide extensive details and convey important information on a timely basis. The Companys philosophy on corporate governance is committed to the highest levels of transparency, accountability, and fairness in every aspect of its operations and in all its interactions with stakeholders, employees, government entities, and lenders. The Company is dedicated to ensuring that all its operations and actions consistently aim to enhance shareholder value over a sustained period.
This approach ensures the Company always maintains a balance between enhancing shareholder wealth and upholding the interests of other stakeholders.
For additional details, please refer to the Companys corporate governance report.
Cautionary Statement
Certain statements in this Management Discussion and Analysis pertaining to KIMS Hospitals objectives, projections, expectations, estimates, future outlook, and other forwardlooking statements are based on currently available information, assumptions, and forecasts, and are subject to applicable laws and regulations. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Companys control, that could cause actual results, performance, or achievements to differ materially from those expressed or implied. Key factors that may
impact actual outcomes include, but are not limited to, changes in macroeconomic conditions, shifts in healthcare regulations or policy, competitive dynamics, pricing pressures, technological advancements, political or economic developments in India and globally, legal proceedings, and fluctuations in input or operational costs.
These statements are not guarantees of future performance and should not be unduly relied upon. KIMS Hospitals undertakes no obligation to publicly update or revise any forward-looking statements in light of future events or new information, except as required by applicable law.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.